Company / Revenue
Cocrystal Pharma, Inc. Revenue History
FY2019-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$6.6M
FY2020
5-year range
$6.6M / $6.6M
FY2019-FY2020
Trend
+0.0%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$7M in FY2020.
Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2020, revenue increased 0.0% year-over-year.
Company context
Key Data Points
- Altman Z-Score 14.87 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2021 | - | - |
| FY2020 | $6.6M | +0.0% |
| FY2019 | $6.6M | - |
| FY2012 | - | - |
As of FY2020 · SEC 10-K · Updated Jun 24, 2026